Literature DB >> 5093706

Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?

G R Constam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5093706     DOI： 10.1007/bf01211874

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  THE VISCERA IN SULFONYLUREA-TREATED DIABETICS.

Authors:  K F WELLMAN; S S LAZARUS; B W VOLK
Journal:  Metabolism       Date:  1963-11       Impact factor: 8.694

2.  The effects of long-term administration of tolbutamide to (alloxan)-subdiabetic rats.

Authors:  A LAZAROW; B TREIBERGS
Journal:  N Engl J Med       Date:  1959-08-27       Impact factor: 91.245

3.  The tolbutamide dilemma.

Authors:  E A HAUNZ
Journal:  J Lancet       Date:  1958-07

4.  Long-term tolbutamide treatment after myocardial infarction. A clinical and biochemical study of 178 patients without overt diabetes.

Authors:  J Paasikivi
Journal:  Acta Med Scand Suppl       Date:  1970
  4 in total
  3 in total

1.  [Oral hypoglycaemic agents and cardiovascular deaths in diabetes].

Authors:  M I Drury; F J Timoney
Journal:  Acta Diabetol Lat       Date:  1972 Jul-Aug

Review 2.  Misunderstanding or error? The UGDP report after four years.

Authors:  S Marigo; L Adezati; P Burnetti; G Pozza; L Robba; G Urbinati
Journal:  Acta Diabetol Lat       Date:  1974 Sep-Oct

3.  Assessment of the need for continued oral therapy in diabetics.

Authors:  A M Tomkins; A Bloom
Journal:  Br Med J       Date:  1972-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.